Protein misfolding has been proposed to be a common pathogenic mechanism in many inborn errors of metabolism including cystathionine β-synthase (CBS) deficiency. In this work, we describe the structural properties of nine CBS mutants that represent a common molecular pathology in the CBS gene. Using thermolysin in two proteolytic techniques, we examined conformation of these mutants directly in crude cell extracts after expression in E. coli. Proteolysis with thermolysin under native conditions appeared to be a useful technique even for very unstable mutant proteins, whereas pulse proteolysis in a urea gradient had limited values for the study of the majority of CBS mutants due to their instability. Mutants in the active core had either slightly increased unfolding (p.A114V, p.E302K and p.G307S) or extensive unfolding with decreased stability (p.H65R, p.T191M, p.I278T and p.R369C). The extent of the unfolding inversely correlated with the previously determined degree of tetrameric assembly and with the catalytic activity. In contrast, mutants bearing aminoacid substitutions in the C-terminal regulatory domain (p.R439Q and p.D444N) had increased global stability with decreased flexibility. This study shows that proteolytic techniques can reveal conformational abnormalities even for CBS mutants that have activity and/or a degree of assembly similar to the wild-type enzyme. We present here a methodological strategy that may be used in cell lysates to evaluate properties of proteins that tend to misfold and aggregate and that may be important for conformational studies of disease-causing mutations in the field of inborn errors of metabolism.

Institute of Inherited Metabolic Disorders 1st Faculty of Medicine Charles University Prague and General University Hospital Prague Ke Karlovu 2 128 08 Prague 2 Czech Republic

See more in PubMed

Beluzic R, Cuk M, Pavkov T, et al. A single mutation at Tyr143 of human S-adenosylhomocysteine hydrolase renders the enzyme thermosensitive and affects the oxidation state of bound cofactor nicotinamide-adenine dinucleotide. Biochem J. 2006;400:245–253. doi: 10.1042/BJ20060749. PubMed DOI PMC

Chang Y, Park C. Mapping transient partial unfolding by protein engineering and native-state proteolysis. J Mol Biol. 2009;393:543–556. doi: 10.1016/j.jmb.2009.08.006. PubMed DOI

Coulter-Mackie MB, Lian Q. Consequences of missense mutations for dimerization and turnover of alanine:glyoxylate aminotransferase: study of a spectrum of mutations. Mol Genet Metab. 2006;89:349–359. doi: 10.1016/j.ymgme.2006.07.013. PubMed DOI

Coulter-Mackie MB, Lian Q. Partial trypsin digestion as an indicator of mis-folding of mutant alanine:glyoxylate aminotransferase and chaperone effects of specific ligands. Study of a spectrum of missense mutants. Mol Genet Metab. 2008;94:368–374. doi: 10.1016/j.ymgme.2008.03.010. PubMed DOI

Erlandsen H, Pey AL, Gamez A, et al. Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations. Proc Natl Acad Sci USA. 2004;101:16903–16908. doi: 10.1073/pnas.0407256101. PubMed DOI PMC

Evande R, Blom H, Boers GH, Banerjee R. Alleviation of intrasteric inhibition by the pathogenic activation domain mutation, D444N, in human cystathionine beta-synthase. Biochemistry. 2002;41:11832–11837. doi: 10.1021/bi026248d. PubMed DOI

Gersting SW, Kemter KF, Staudigl M, et al. Loss of function in phenylketonuria is caused by impaired molecular motions and conformational instability. Am J Hum Genet. 2008;83:5–17. doi: 10.1016/j.ajhg.2008.05.013. PubMed DOI PMC

Gupta S, Wang L, Hua X, Krijt J, Kozich V, Kruger WD. Cystathionine beta-synthase p.S466L mutation causes hyperhomocysteinemia in mice. Hum Mutat. 2008;29:1048–1054. doi: 10.1002/humu.20773. PubMed DOI PMC

Hnizda A, Spiwok V, Jurga V, Kozich V, Kodicek M, Kraus JP. Cross-talk between the catalytic core and the regulatory domain in cystathionine beta-synthase: Study by differential covalent labeling and computational modelling. Biochemistry. 2010;49:10526–10534. doi: 10.1021/bi101384m. PubMed DOI PMC

Janosik M, Kery V, Gaustadnes M, Maclean KN, Kraus JP. Regulation of human cystathionine beta-synthase by S-adenosyl-L-methionine: evidence for two catalytically active conformations involving an autoinhibitory domain in the C-terminal region. Biochemistry. 2001;40:10625–10633. doi: 10.1021/bi010711p. PubMed DOI

Janosik M, Oliveriusova J, Janosikova B, et al. Impaired heme binding and aggregation of mutant cystathionine beta-synthase subunits in homocystinuria. Am J Hum Genet. 2001;68:1506–1513. doi: 10.1086/320597. PubMed DOI PMC

Kery V, Poneleit L, Kraus JP. Trypsin cleavage of human cystathionine beta-synthase into an evolutionarily conserved active core: structural and functional consequences. Arch Biochem Biophys. 1998;355:222–232. doi: 10.1006/abbi.1998.0723. PubMed DOI

Kim MS, Song J, Park C. Determining protein stability in cell lysates by pulse proteolysis and Western blotting. Protein Sci. 2009;18:1051–1059. doi: 10.1002/pro.115. PubMed DOI PMC

Kopecka J, Krijt J, Rakova K, Kozich V. Restoring assembly and activity of cystathionine beta-synthase mutants by ligands and chemical chaperones. J Inherit Metab Dis. 2011;34:39–48. doi: 10.1007/s10545-010-9087-5. PubMed DOI PMC

Kozich V, Kraus JP. Screening for mutations by expressing patient cDNA segments in E. coli: homocystinuria due to cystathionine beta-synthase deficiency. Hum Mutat. 1992;1:113–123. doi: 10.1002/humu.1380010206. PubMed DOI

Kozich V, Sokolova J, Klatovska V, et al. Cystathionine beta-synthase mutations: effect of mutation topology on folding and activity. Hum Mutat. 2010;31:809–819. doi: 10.1002/humu.21273. PubMed DOI PMC

Leandro P, Gomes CM. Protein misfolding in conformational disorders: rescue of folding defects and chemical chaperoning. Mini Rev Med Chem. 2008;8:901–911. doi: 10.2174/138955708785132783. PubMed DOI

Maclean KN, Gaustadnes M, Oliveriusova J, et al. High homocysteine and thrombosis without connective tissue disorders are associated with a novel class of cystathionine beta-synthase (CBS) mutations. Hum Mutat. 2002;19:641–655. doi: 10.1002/humu.10089. PubMed DOI

Maier EM, Gersting SW, Kemter KF, et al. Protein misfolding is the molecular mechanism underlying MCADD identified in newborn screening. Hum Mol Genet. 2009;18:1612–1623. doi: 10.1093/hmg/ddp079. PubMed DOI PMC

Majtan T, Liu L, Carpenter JF, Kraus JP. Rescue of cystathionine beta-synthase (CBS) mutants with chemical chaperones: purification and characterization of eight CBS mutant enzymes. J Biol Chem. 2010;285:15866–15873. doi: 10.1074/jbc.M110.107722. PubMed DOI PMC

Meier M, Oliveriusova J, Kraus JP, Burkhard P. Structural insights into mutations of cystathionine beta-synthase. Biochim Biophys Acta. 2003;1647:206–213. PubMed

Mudd SH, Levy LH, Kraus JP (2001) Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Vale D, Childs B, Vogelstein B (eds) The metabolic and molecular bases of inherited disease, 7th edn. McGraw-Hill, 1007–1056

Muntau AC, Gersting SW. Phenylketonuria as a model for protein misfolding diseases and for the development of next generation orphan drugs for patients with inborn errors of metabolism. J Inherit Metab Dis. 2010;33:649–658. doi: 10.1007/s10545-010-9185-4. PubMed DOI

Muntau AC, Roschinger W, Habich M, et al. Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria. N Engl J Med. 2002;347:2122–2132. doi: 10.1056/NEJMoa021654. PubMed DOI

Park C, Marqusee S. Analysis of the stability of multimeric proteins by effective DeltaG and effective m-values. Protein Sci. 2004;13:2553–2558. doi: 10.1110/ps.04811004. PubMed DOI PMC

Park C, Marqusee S. Probing the high energy states in proteins by proteolysis. J Mol Biol. 2004;343:1467–1476. doi: 10.1016/j.jmb.2004.08.085. PubMed DOI

Park C, Marqusee S. Pulse proteolysis: a simple method for quantitative determination of protein stability and ligand binding. Nat Methods. 2005;2:207–212. doi: 10.1038/nmeth740. PubMed DOI

Park C, Marqusee S. Quantitative determination of protein stability and ligand binding by pulse proteolysis. In: Coligan JE, Dunn BM, Speicher DW, Wingfield PT, Ploegh HL, editors. Current protocols in protein sciences. Hoboken: Wiley; 2006. pp. 20.11.1–20.11.14. PubMed

Perez B, Desviat LR, Gomez-Puertas P, Martinez A, Stevens RC, Ugarte M. Kinetic and stability analysis of PKU mutations identified in BH4-responsive patients. Mol Genet Metab. 2005;86(Suppl 1):S11–S16. doi: 10.1016/j.ymgme.2005.06.009. PubMed DOI

Pey AL, Perez B, Desviat LR, et al. Mechanisms underlying responsiveness to tetrahydrobiopterin in mild phenylketonuria mutations. Hum Mutat. 2004;24:388–399. doi: 10.1002/humu.20097. PubMed DOI

Prudova A, Bauman Z, Braun A, Vitvitsky V, Lu SC, Banerjee R. S-adenosylmethionine stabilizes cystathionine beta-synthase and modulates redox capacity. Proc Natl Acad Sci USA. 2006;103:6489–6494. doi: 10.1073/pnas.0509531103. PubMed DOI PMC

Schiff M, Froissart R, Olsen RK, Acquaviva C, Vianey-Saban C. Electron transfer flavoprotein deficiency: functional and molecular aspects. Mol Genet Metab. 2006;88:153–158. doi: 10.1016/j.ymgme.2006.01.009. PubMed DOI

Schlebach JP, Kim MS, Joh NH, Bowie JU, Park C. Probing membrane protein unfolding with pulse proteolysis. J Mol Biol. 2010;406:545–551. doi: 10.1016/j.jmb.2010.12.018. PubMed DOI PMC

Sen S, Banerjee R. A pathogenic linked mutation in the catalytic core of human cystathionine beta-synthase disrupts allosteric regulation and allows kinetic characterization of a full-length dimer. Biochemistry. 2007;46:4110–4116. doi: 10.1021/bi602617f. PubMed DOI PMC

Sen S, Yu J, Yamanishi M, Schellhorn D, Banerjee R. Mapping peptides correlated with transmission of intrasteric inhibition and allosteric activation in human cystathionine beta-synthase. Biochemistry. 2005;44:14210–14216. doi: 10.1021/bi051046d. PubMed DOI

Singh LR, Kruger WD. Functional rescue of mutant human cystathionine beta-synthase by manipulation of Hsp26 and Hsp70 levels in Saccharomyces cerevisiae. J Biol Chem. 2009;284:4238–4245. doi: 10.1074/jbc.M806387200. PubMed DOI PMC

Singh LR, Chen X, Kozich V, Kruger WD. Chemical chaperone rescue of mutant human cystathionine beta-synthase. Mol Genet Metab. 2007;91:335–342. doi: 10.1016/j.ymgme.2007.04.011. PubMed DOI PMC

Singh LR, Gupta S, Honig NH, Kraus JP, Kruger WD. Activation of mutant enzyme function in vivo by proteasome inhibitors and treatments that induce Hsp70. PLoS Genet. 2010;6:e1000807. doi: 10.1371/journal.pgen.1000807. PubMed DOI PMC

Skovby F, Gaustadnes M, Mudd SH. A revisit to the natural history of homocystinuria due to cystathionine beta-synthase deficiency. Mol Genet Metab. 2010;99:1–3. doi: 10.1016/j.ymgme.2009.09.009. PubMed DOI PMC

Waters PJ, Parniak MA, Akerman BR, Jones AO, Scriver CR. Missense mutations in the phenylalanine hydroxylase gene (PAH) can cause accelerated proteolytic turnover of PAH enzyme: a mechanism underlying phenylketonuria. J Inherit Metab Dis. 1999;22:208–212. doi: 10.1023/A:1005533825980. PubMed DOI

Yamanishi M, Kabil O, Sen S, Banerjee R. Structural insights into pathogenic mutations in heme-dependent cystathionine-beta-synthase. J Inorg Biochem. 2006;100:1988–1995. doi: 10.1016/j.jinorgbio.2006.08.020. PubMed DOI

Young TA, Skordalakes E, Marqusee S. Comparison of proteolytic susceptibility in phosphoglycerate kinases from yeast and E. coli: modulation of conformational ensembles without altering structure or stability. J Mol Biol. 2007;368:1438–1447. doi: 10.1016/j.jmb.2007.02.077. PubMed DOI

A proactive genotype-to-patient-phenotype map for cystathionine beta-synthase

Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency

Chaperone therapy for homocystinuria: the rescue of CBS mutations by heme arginate

Conformational properties of nine purified cystathionine β-synthase mutants